Apart from neurological diseases involving BBB disruption, it has been shown that PDGF-CC can facilitate tumour growth by recruiting cancer-associated fibroblasts (CAFs) and by increasing tumour angiogenesis [16]. This evidence concerns the gene CXCR1 and cancer.